CBD-based Therapy to Attenuate Non-bacterial Prostatitis Symptoms
CompletedNot applicableNCT06968910
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Efficacy and safety of the medical device rectal CANNEFF® SUP suppositories containing two active ingredients cannabidiol (CBD) and hyaluronic acid (HA) in alleviating non-bacterial prostatitis symptoms and improving quality of life in men will be evaluated.
Study details
- Official title
- Cannabidiol-based Therapy to Attenuate Non-bacterial Prostatitis Symptoms - Single-arm Open-label Pilot Clinical Trial With Intrarectal Administration
- Conditions
- Interventions
- Device: CANNEFF® SUP rectal suppositories
- Sponsor
- Palacky University
- Collaborators
- CB21 Pharma Ltd.
- Start date
- 2022-12-01
- Primary completion
- 2024-04-01
- Sex
- Male
- Age range
- from 18 Years to 50 Years
- Results posted
- No results posted in this snapshot
- Countries
- Czechia
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * men aged 18-50 years * reported pelvic pain for ≥3 months in the past 6 months * reported the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) total score \>10 with a pain subscore ≥4 * clinically and laboratory diagnosed CP/CPPS Exclusion Criteria: * confirmed genitourinary infections (e.g., Escherichia coli, Enterococcus faecalis, Chlamydia spp.) * recent antibiotic use (within 6 months) * cannabis use * alpha-blockers or phytotherapeutics in the preceding 4 weeks * no history of pelvic trauma, surgery or radiotherapy, neurogenic bladder, post-void residual \>50 mL, or psychiatric disorders affecting compliance
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06968910